Zealand Pharma publishes Phase 2 petrelintide trial results in The Lancet

September 29, 2026 6:03 PM

Zealand Pharma A/S (Nasdaq: ZEAL) announced that results from its Phase 2 ZUPREME-1 trial evaluating petrelintide, an investigational weight management ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found